# Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition

> **NCT04445922** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 26 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** test-anastrozole tablet (Salutas Pharma GmbH)
- **DRUG:** reference-anastrozole tablet

## Key facts

- **NCT ID:** NCT04445922
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-04
- **Primary completion:** 2020-08-03
- **Final completion:** 2020-10-30
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04445922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04445922, "Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04445922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*